Hubbry Logo
search button
Sign in
Cenerimod
Cenerimod
Comunity Hub
arrow-down
History
arrow-down
starMore
arrow-down
bob

Bob

Have a question related to this hub?

bob

Alice

Got something to say related to this hub?
Share it here.

#general is a chat channel to discuss anything related to the hub.
Hubbry Logo
search button
Sign in
Cenerimod
Community hub for the Wikipedia article
logoWikipedian hub
Welcome to the community hub built on top of the Cenerimod Wikipedia article. Here, you can discuss, collect, and organize anything related to Cenerimod. The purpose of the hub is to connect people, foste...
Add your contribution
Cenerimod

Cenerimod
Clinical data
Other namesACT-334441
Legal status
Legal status
  • Investigational
Identifiers
  • (2S)-3-[4-[5-(2-cyclopentyl-6-methoxypyridin-4-yl)-1,2,4-oxadiazol-3-yl]-2-ethyl-6-methylphenoxy]propane-1,2-diol
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC25H31N3O5
Molar mass453.539 g·mol−1
3D model (JSmol)
  • CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC(=C3)OC)C4CCCC4)C)OC[C@H](CO)O
  • InChI=1S/C25H31N3O5/c1-4-16-10-18(9-15(2)23(16)32-14-20(30)13-29)24-27-25(33-28-24)19-11-21(17-7-5-6-8-17)26-22(12-19)31-3/h9-12,17,20,29-30H,4-8,13-14H2,1-3H3/t20-/m0/s1
  • Key:KJKKMMMRWISKRF-FQEVSTJZSA-N

Cenerimod is an investigational new drug that is being evaluated for the treatment of systemic lupus erythematosus.[1] It is a sphingosine-1-phosphate receptor modulator.[2]

References

[edit]
  1. ^ "Cenerimod - Idorsia Pharmaceuticals". AdisInsight. Springer Nature Switzerland AG.
  2. ^ Piali L, Birker-Robaczewska M, Lescop C, Froidevaux S, Schmitz N, Morrison K, et al. (December 2017). "Cenerimod, a novel selective S1P1 receptor modulator with unique signaling properties". Pharmacology Research & Perspectives. 5 (6). doi:10.1002/prp2.370. PMC 5723703. PMID 29226621.